Clinical decision support
The company has received 12 US FDA approvals.
Kauvery Hospital invests in Lifesigns
Lifesigns has received undisclosed funding from Kauvery Hospital Group's investment arm, Healthcare Capital.
The Orthopaedic Surgery team has recently received an international patent for the novel AI for robotic total knee replacement.
The Australian-led project developed these maps, claimed to be the most detailed ever made, to link retinal thinning to various diseases.
Its developer, a spinoff from Nanyang Technological University, Singapore, is looking to raise up to $1.5 million to commercialise their MCI screening tool.
The funding, which is NRFC's first medical science investment, will help introduce the company's AI to more health facilities locally and abroad.
Also, a new mobile app in Australia tracks eyelid movement to detect sleep apnoea.
Also, fitness technology company GOQii has introduced an AI-powered post-organ transplant care programme.
Zhenya Lindgardt, CEO of Sera Prognostics, joined MobiHealthNews to discuss the company's trial on lessening the rate of preterm births.
The Sentinel Camera allows point-of-care retinal imaging and eliminates the need for a visit to an eye specialist's office.